Tag: ICH stability guidelines,

How to Address Stability Testing Requirements for Global Harmonization under ICH Guidelines Global Harmonization of Stability Testing: Navigating ICH Guidelines Introduction Global harmonization of stability testing is crucial for ensuring consistent quality, safety, and efficacy of pharmaceutical products across different markets. The International Council for Harmonisation (ICH) provides guidelines that unify stability testing requirements for…

Read More “How to Address Stability Testing Requirements for Global Harmonization under ICH Guidelines” »

How to Implement Stability Testing for Orally Inhaled and Nasal Drug Products (OINDP) under FDA Guidelines Ensuring Stability of Orally Inhaled and Nasal Drug Products: A Guide to FDA Compliance Introduction Orally Inhaled and Nasal Drug Products (OINDPs), including inhalers, nasal sprays, and nebulizers, are complex formulations that require rigorous stability testing to ensure their…

Read More “How to Implement Stability Testing for Orally Inhaled and Nasal Drug Products (OINDP) under FDA Guidelines” »

How to Conduct Stability Studies for Controlled Drugs under Regulatory Guidelines Ensuring Compliance in Stability Studies for Controlled Drugs Introduction Controlled drugs, including narcotics and psychotropics, require stringent stability testing to ensure their safety, efficacy, and quality throughout their shelf life. Regulatory authorities, such as the US DEA, FDA, and international bodies, provide specific guidelines…

Read More “How to Conduct Stability Studies for Controlled Drugs under Regulatory Guidelines” »

How to Address Stability Testing for Products under Emergency Use Authorization (EUA) Stability Testing for Products under EUA: Navigating Regulatory Requirements Introduction Emergency Use Authorization (EUA) allows for the use of medical products during public health emergencies, even when they have not completed the standard approval process. Stability testing for products under EUA is crucial…

Read More “How to Address Stability Testing for Products under Emergency Use Authorization (EUA)” »

How to Implement Stability Testing for High-Risk Drug Products under Regulatory Guidelines Stability Testing for High-Risk Drug Products: Regulatory Compliance Guide Introduction High-risk drug products, such as controlled substances, cytotoxic agents, and biologics, require stringent stability testing to ensure their safety, efficacy, and quality. Regulatory authorities, including the US FDA, EMA, and WHO, have established…

Read More “How to Implement Stability Testing for High-Risk Drug Products under Regulatory Guidelines” »

How to Conduct Stability Studies for Drugs with Narrow Therapeutic Index under US FDA Guidelines Stability Studies for Drugs with Narrow Therapeutic Index: A Guide to US FDA Compliance Introduction Drugs with a narrow therapeutic index (NTI) have a small margin between therapeutic and toxic doses, making precise and rigorous stability testing essential to ensure…

Read More “How to Conduct Stability Studies for Drugs with Narrow Therapeutic Index under US FDA Guidelines” »

How to Implement Stability Testing for Non-Oral Dosage Forms in Compliance with Regulatory Guidelines Ensuring Compliance in Stability Testing for Non-Oral Dosage Forms Introduction Non-oral dosage forms, such as injectables, inhalers, transdermal patches, and ophthalmic solutions, present unique challenges in stability testing due to their distinct formulations, delivery mechanisms, and storage conditions. Ensuring compliance with…

Read More “How to Implement Stability Testing for Non-Oral Dosage Forms in Compliance with Regulatory Guidelines” »